Summary:
This is a 12-week, double blind, randomized placebo-controlled study of Mesafem 7.5 mg capsules in subjects experiencing moderate to severe postmenopausal hot flashes.
Qualified Participants Must:
• Be a female over 40 years of age
•
Have had spontaneous menstruals over the past 6 months to 1 year
•
Have discontinued all psychotropic drugs and any hormonal medications
Qualified Participants May Receive:
Free medication, medical care, lab work, physical exam, echocardiogram, and vital signs. You may be eligible to receive compensation for your time and travel.